| Identification | Back Directory | [Name]
Acetamide, N-[3-[2-[2-(3-aminopropoxy)ethoxy]ethoxy]propyl]-2-[[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]oxy]-, hydrochloride (1:1) | [CAS]
2564466-93-7 | [Synonyms]
Thalidomide-O-amido-C1-PEG3-C3-NH2 hydrochloride
Acetamide, N-[3-[2-[2-(3-aminopropoxy)ethoxy]ethoxy]propyl]-2-[[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]oxy]-, hydrochloride (1:1) | [Molecular Formula]
C25H35ClN4O9 | [MOL File]
2564466-93-7.mol | [Molecular Weight]
571.02 |
| Hazard Information | Back Directory | [Description]
Functionalized cereblon ligand for PROTAC® research and development; incorporates an E3 ligase ligand plus an alkylC1-PEG3-alkylC3 linker with terminal amine ready for conjugation to a target protein ligand. Part of a range of functionalized tool molecules for PROTAC R&D. PROTAC® is a registered trademark of Arvinas Operations, Inc., and is used under license. | [Uses]
Thalidomide 4'-oxyacetamide-C1-PEG3-C3-amine hydrochloride is a functionalized cereblon ligand for PROTAC research and development with terminal amine ready for conjugation to a target protein ligand[1]. | [IC 50]
Cereblon | [storage]
Store at -20°C | [References]
[1] Nabet B, et al. The dTAG system for immediate and target-specific protein degradation. Nat Chem Biol. 2018 May;14(5):431-441. DOI:10.1038/s41589-018-0021-8 |
|
|